News and Announcements
Millenium Kapital prepares for 2019 IPO with appointment of new advisors
- Published January 07, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Millenium Kapital Ltd appoints new advisors.
- Advisors have been appointed in order to prepare the company for an IPO.
- MKL is in the final stage of its Pre IPO raising.
Millenium Kapital Ltd (BVI) is pleased to confirm the appointment of the following advisors which will prepare the company for an IPO early this year.
- Hill Dickinson LLP (UK) – Legal Advisors to the Company as to English law and will lead the IPO Team.
- Walkers (Singapore) LLP – Legal Advisors to the Company as to British Virgin Islands law.
- Tito Isaac & Co LLP – Legal Advisors to the Company as to Singapore law.
- Price Sierakowski – Legal Advisors to the Company as to Australia law.
- RSM Corporate Finance LLP (UK)- Auditors.
- Wholesale Investor (AU) – Private Investment Platform.
MKL is in the final stage of its Pre IPO raising which is at 2p and expects to move to the Prospectus stage sometime mid to end February 2019 in preparation for its IPO.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
